Life Rx Celebrates Helping 35,000 Patients Achieve Wellness Success 
Evotec to Attend Upcoming Investor Conferences
HAMBURG, GERMANY / ACCESSWIRE / March 7, 2019 / Evotec AG (FSE: EVT, OTC PINK: EVTCY, MDAX/TecDAX, ISIN: DE0005664809) announced...
Evitrade Subsidiary Closes Joint Venture With Hemp Industry Target In Nevada
VANCOUVER, BC / ACCESSWIRE / March 7, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the "Company") is...
CorMedix Inc. to Report Year Ended December 31, 2018 Financial Results on Thursday, March 14
BERKELEY HEIGHTS, NJ / ACCESSWIRE / March 7, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on...
Association of Bioscience Financial Officers Introduces Speaker Line-Up for 2019 National Conference Set for May 28-31 in Boston
Association of Bioscience Financial Officers Introduces Speaker Line-Up for 2019 National Conference Set for May 28-31 in Boston BOSTON, MA...
Apogenix Announces Oral and Poster Presentations at Upcoming International Conferences
HEIDELBERG, GERMANY / ACCESSWIRE / March 7, 2019 / Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today...
Prevent Announces Completion of Unit Offering
CALGARY, AB / ACCESSWIRE / March 6, 2019 / Prevent Health Care International Corp. (the "Corporation" or "Prevent") today announced...
Certive Announces Expanded Scope of Work with Major Client
Certive Announces Expanded Scope of Work with Major Client and the Closing of its Current Convertible Debt Offering SCOTTSDALE, AZ...
Award Received from the Sexual Medicine Society of North America to Fund a Targazyme TZ101 Study to Reverse Erectile Dysfunction in Prostate Cancer Patients
SAN DIEGO, CA / ACCESSWIRE / March 6, 2019 / Targazyme, a clinical-stage biopharmaceutical company developing novel enzyme products to...
Innovative Medicines Canada Responds to Release of Interim Report of the Advisory Council for the Implementation of National Pharmacare
OTTAWA, ON / ACCESSWIRE / March 6, 2019 / Today's announcement on national pharmacare is an important step forward in...
Pharnext: Reinforcement of Pharnext Equity Capital by Conversion of Convertibles Bonds
PARIS, FRANCE / ACCESSWIRE / March 6, 2019 / Pharnext SA (FR0011191287 - ALPHA), a biopharmaceutical company pioneering a new...
Zynex to Present at the 2019 LD Micro Virtual Conference
LOS ANGELES, CA / ACCESSWIRE / March 6, 2019 / Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing...
Aytu BioScience Announces ZolpiMist(TM) Global Distribution Agreement with SUDA Pharmaceuticals
Aytu Assumes Milestone & Royalty-Based Licensing Agreement with SUDA Pharmaceuticals to Sublicense ZolpiMist Outside of the United States and Canada...
Champions Oncology to Announce Third Quarter Financial Results on Monday, March 18, 2019
HACKENSACK, NJ / ACCESSWIRE / March 6, 2019 / Champions Oncology, Inc. (NASDAQ: CSBR), engaged in an end-to-end range of...
Alimera Sciences Announces the Reimbursement of ILUVIEN(R) in France
France is a Significant Market for Intravitreal Steroid Use ATLANTA, GA / ACCESSWIRE / March 6, 2019 / Alimera Sciences,...
Cerecor Announces $8 Million Bought Deal Offering
ROCKVILLE MD / ACCESSWIRE / March 5, 2019 / Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a...
Heat Biologics Lead Director to Chair Oncology Roundtable Discussion at WuXi Healthcare Forum in Shanghai
DURHAM, NC / ACCESSWIRE / March 5, 2019 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing "off-the-shelf" T-cell...
Jaguar Health, Inc. Reports Voting Results from February 28, 2019 Special Meeting of Stockholders
All Proposals ApprovedSAN FRANCISCO, CA / ACCESSWIRE / March 5, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) (''Jaguar'' or the...
Dynatronics to Participate in Canaccord’s 2019 Musculoskeletal Conference in Las Vegas, Nevada
COTTONWOOD HEIGHTS, UT / ACCESSWIRE / March 5, 2019 / Dynatronics Corporation (NASDAQ: DYNT), a leading provider of physical therapy,...
Pieris Pharmaceuticals to Host Full-Year 2018 Investor Call and Corporate Update on March 12, 2019
BOSTON, MA / ACCESSWIRE / March 5, 2019 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a biotechnology company advancing novel biotherapeutics...
Viveve to Present at Cowen and Company 39th Annual Health Care Conference
ENGLEWOOD, CO / ACCESSWIRE / March 5, 2019 / Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on...